MarketScreener Strategies Protalix BioTherapeutics, Inc. TEL AVIV STOCK EXCHANGE
Stocks
PLX
US74365A3095
Pharmaceuticals
|
Delayed
TEL AVIV STOCK EXCHANGE
11:24:48 2023-03-21 EDT
|
5-day change | 1st Jan Change | ||
| 732.50 ILa | -.--% |
|
+3.29% | +69.68% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
MarketScreener Strategies
Search
No results match your criteria
- Stock Market
- Stocks
- PLX Stock
- PLX Stock
- News Protalix BioTherapeutics, Inc.
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
